* Instil Bio Inc TIL.OQ reported a quarterly adjusted loss
of 14
cents per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 16 cents per share.
* Reported revenue was zero; analysts expected zero.
* Instil Bio Inc's reported EPS for the quarter was a loss
of 14
cents.
* The mean earnings estimate of analysts had fallen by
about 63.3%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Instil Bio Inc shares had fallen by 5.4% this quarter and
lost 17.3% so far this year.
* The company reported a quarterly loss of $18.66 million.
* Wall Street's median 12-month price target for Instil Bio
Inc is
$5.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 14 at 12:01 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.16 -0.14 Beat
Mar. 31 2023 -0.15 -0.44 Missed
Dec. 31 2022 -0.41 -0.24 Beat
Sep. 30 2022 -0.44 -0.43 Beat